The vital role of the cardiovascular (CV) system is maintenance of body functions via the matching of exchange to tissue metabolic demand. Sex-specific differences in the regulatory mechanisms of CV function and the metabolic requirements of men and women, respectively, have been identified and appreciated. This review focuses on sex differences of parameters influencing exchange at the point of union between blood and tissue, the microvasculature. Microvascular architecture, blood pressure (hydrostatic and oncotic), and vascular permeability, therefore, are discussed in the specific context of sex in health and disorders. It is notable that when sex differences exist, they are generally subtle but significant. In the aggregate, though, they can give rise to profoundly different phenotypes. The postulated mechanisms responsible for sex differences are attributed to genomics, epigenetics, and sex hormones. Depending on specific circumstances, the effect of the combined factors can range from insignificant to lethal. Identifying and understanding key signalling mechanisms bridging genomics/sex hormones and microvascular exchange properties within the scope of this review holds significant promise for sex-specific prevention and treatment of vascular barrier dysfunction.
Introduction
Fluid distribution between the vascular and tissue compartments in all living beings is a controlled variable. Volume homeostasis, as proposed by Starling in 1896, is achieved when the forces governing fluid movement, set up by transmural gradients in hydrostatic (DP) and oncotic (Dp) pressures, are in balance. 1 Unstated assumptions are that the mechanisms whereby fluid homeostasis is achieved, how they vary with disease, and how they respond to treatments are the same for males and females. This brief review explores the extent to which these assumptions are true, when they appear not to be true, why we care, and what research needs to be conducted. Features of the cardiovascular (CV) system known to differ with sex and unlikely to impact exchange directly include the smaller-sized heart and major blood vessels of women relative to men of the same race and age. In most organs, the anatomical location of the major vessels is indistinguishable among the sexes. In males and females, the same formed elements circulate in blood, the vessels are composed of the same cell types, and the union of the elements performs the same functions. Healthy males and females are in homeostasis. Consequently, the conclusion that the functions and responses of these common elements do not differ with sex is not outlandish. In fact, notable features exist that influence basal function in men and women differently, those that induce sex-linked responses, those that are indistinguishable between the sexes, and yet others that, while appearing to differ, are without known functional consequence.
The premise of this review is that while both sexes possess the same structural elements and are in fluid balance, how those elements function to achieve homeostasis with respect to the CV system differs (from subtly to profoundly). Manifestations of these differences have real consequences relative to how and when fluid and solute exchange are disrupted, how these dysfunctions can be prevented, and the strategies for ameliorating or treating these manifestations effectively. To students of physiology, both differences and similarities are of importance as they provide fundamental insight into the mechanisms regulating the integrated functions of the intact organism.
There are a paucity of studies on humans or animals comparing fluid or solute exchange in males and females, whether animal or human. In the absence of these data, most of what is presented comes from comparisons of studies on one sex or limited studies on both sexes of a feature likely to influence exchange and then incorporated into the 'big picture'. The goal is to raise awareness, if not research interest, in missing gaps to be filled.
Fundamentally, it is not surprising that men and women can differ. At the very least, cells from males contain a Y chromosome, express the Sry gene, and males produce testosterone (T) in the testes ( Table 1) . Cells from females have two X chromosomes; females produce oestrogen (oestradiol, E2) and progesterone (pregn-4-ene-3,20-dione, P4) in the ovaries. Sex-specific differences and similarities in the CV system result from more than sex hormones, per se. It is essential to realize that every cell of the body has 'sex' due to the presence of either XX or XY chromosomes, that sex is manifest in the womb, and that beyond behaviour, biological differences exist in the CV system before puberty.
Determinants of whole body fluid balance
The place to initiate investigation of where sex may influence net fluid and/or solute movement is with the governing equations.
Volume flux, J v
Fluid movement (J v , volume flux, mL s 21 ) is generally described by the modern form of the Starling expression:
where L p is hydraulic conductivity (cm s 21 mmHg 21 , a coefficient describing barrier leakiness to water), DP and Dp are the hydrostatic and oncotic pressure difference between the vascular and tissue spaces, respectively, and s, a unit-less coefficient, is the osmotic reflection coefficient. In whole organs or intact tissues, CFC (or K f ), the capillary filtration coefficient represents the L p of N exchange microvessels of surface area S. The net filtration pressure (NFP) represents the sum of the hydrostatic and effective osmotic forces acting across the exchange vessel walls. A slight imbalance in DP and sDp exists under basal conditions such that NFP is positive, resulting in net fluid movement (capillary filtration) into the tissue. This is offset by removal of interstitial fluid via the lymphatics. Thus, in volume balance, J v from all perfused vessels is equal to lymph flow and interstitial fluid volume is constant.
Solute flux, J s
Exchange involves solute and fluid movement as Dp is driven by the distribution of hydrophilic molecules across the barrier. As stated by Fick's first law of diffusion, solutes move across the vascular barrier when a concentration gradient (DC, mmole mL 21 ) exists:
Here J s is solute flux (mmole s
21
) and P d is the diffusive permeability coefficient (cm s 21 ):
where D f is the solute's free diffusion coefficient (cm 2 s 21 ) and Dx is barrier thickness (cm).
When fluid and solute interact, s = 1
In most organs, the exchange vessels are classified as continuous and s to proteins is near 1. 14-95.6 1 -11. 4 7.7 -58.5 diffuse between the vascular and interstitial spaces, but changes in DP can lead to faster than expected movement when solutes with low D f (proteins) become entrained with J v. The importance of 'solvent drag' or convection, expressed by a hairy set of Eqs. (4) (5) (6) (7) , is that fluid movement influences macromolecule distribution and vice versa. For completeness, J s under these circumstances is:
where Pé is the Péclet number:
Pé provides a determination of how much of J s, at a given pressure, results from fluid movement relative to diffusive mechanisms. At Pé , 0.2 diffusive mechanisms predominate and Fick's first law [Eq. (2)] applies. When Pé . 5 (i.e. volume flux .. diffusive flux) the solute moves primarily by convection; Eq. (4) reduces to:
For J v , if microvessel pressures keep changing thus providing insufficient time for moving solute to alter the transvascular gradients the modified Starling equation [Eq. (1)] holds. Otherwise, if solute and fluid flux together the gradients will change and a steady-state condition can be achieved wherein the transvascular osmotic gradient influences steady-state filtration:
The steady state filtration relationship is non-linear until high pressures are reached (Pé . 5) and the relationship of J v /S with P parallels Eq. (1) with a limiting slope ¼ L p . The other notable feature of this relationship is that capillaries and venules exposed to fairly constant hydrostatic pressures have from negligible to appreciable constant filtration and cannot sustain fluid re-absorption from the interstitium into the vasculature. Of note, collecting lymphatics contract spontaneously under physiological conditions and could support both transient re-absorption and filtration 2 by failing to achieve steady-state conditions. The equations illustrate that multiple parameters influence exchange substantially. The extent to which they differ by sex in health and/or disease is not well defined.
2.4
The forces: hydrostatic, P, and oncotic, p, pressure While text books refer to 'normal' arterial blood pressure (BP) as 120/80 mmHg, the BP of healthy adult human females is lower than males. Data from the second (US) National Health and Nutritional Examination Survey (n ¼ 22 732) 3 show ( 3 The net result is a pulse pressure (SBP-DBP), greater in males, that increases by 0.4 mmHg/year and 0.6 mmHg/year in males and females, respectively, between the ages of 35 -59.
Capillary pressure, P c
The inference from these data, given the anatomical location of exchange vessels downstream of resistance vessels, is that up to age 65, capillary pressure, P c , is lower in women than men. Direct measurements of P c 4 confirm lower values in pre-menopausal women than men ( Table 2 ). The caveat is that arterial BP, SBP, DBP, or mean (MAP), do not relate directly with P c . 4 This lack of direct correlation between SBP and P c confirms the demonstration 5 of mechanisms protecting the exchange vasculature from changes in arterial BP. Table 3) . Venous capacitance is lower in age-matched females than males. After correction for fluid filtration, venous compliance at low transmural pressures is lower in women (e.g. for a given pressure, the veins of women can accommodate a greater change in volume). 7 With respect to pressure transmission into the exchange vasculature, for a given increase in venous volume, hydrostatic pressures would be anticipated to rise more quickly in men than women.
Oncotic pressures and plasma protein content
The oncotic pressure (p) is a direct function of protein concentration (p ¼ FnC, where F is a correction coefficient, n is valence number, and C is molar concentration) in the vascular and tissue compartments, respectively. Under physiological conditions, p is presumed constant. The major determinant of p in blood is plasma protein concentration, with albumin playing a dominant role. According to the NHANES II data set, 8 plasma protein levels averaged for all ages (6-74 years) are sex-independent ( Table 2) . Inspection of Figure 1A reveals a complex temporal pattern. Before age 14, serum protein levels are sex-independent. The greatest sex difference, 0.3 g/dL, occurs between 18 and 24 years; after which albumin levels in both sexes decline until they again are sex-independent for 55 -74 years old. The influence of plasma protein content on p is illustrated in Figure 1B . As comprehensive a data set as NHANES does not seem to exist with measures of total serum protein. If albumin is assumed to be a constant proportion of total protein (e.g. 69% of 7 g/dL total protein plasma contains 4.8 g/dL albumin 9 ), mean p is 25.7 mmHg for males and 24.9 mmHg for females for ages 6-74.
Net filtration pressure
The consequence of sex differences in P c and p is that the 2.3 mmHg M/F difference in P c observed by Shore et al. 4 is offset by at least 1 mmHg M/F difference in p. Noteworthy is that when exchange P c becomes sex-independent (.65 years), p also is sex-independent. Surface area in addition to the DP and Dp will limit water and solute exchange. As an architectural parameter, S is a function of microvessel number, length, and diameter. If volume homeostasis is presumed to be the same between sexes, then the parameters determining S should likewise be sex-independent.
Anatomical structure
This appears to be true in the absence of 'stress'. Vascular architecture can differ significantly in response to exercise training, 12 heart failure, 12 hypertension (HTN), 12 and diabetes, 13 to mention a few cases ( Table 3) . In a rat model of HTN, MAP in males rises at an earlier age and is accompanied by significant loss of skeletal muscle (SKM) microvessels (rarefaction); in females, MAP rises less and is unassociated with rarefaction. 12 In humans, exercise training improves submaximal performance in men, not women, although capillary density is increased in both sexes. 14 When peak oxygen consumption and vastus lateralis capillary density were examined in chronic heart failure patients, they varied inversely for men and were unrelated for women. 15 A well-delineated sexually dimorphic component influencing microvessel structure is the growth of arteriolar vascular smooth muscle (VSM) cells from normotensive and HTN rats, 16 which in turn would be expected to influence vascular reactivity.
Vascular tone and functional structure
A more important means of varying S in the intact circulation is through mechanisms usually studied with respect to blood flow regulation and associated with arteriolar vascular tone. As outlined above, arterial pressures, per se, do not correlate directly with P c . Arteriolar vasodilatation, though, will reduce pre-capillary resistance and increase vascular exchange via perfusion of additional capillaries (functional vs. anatomical change in S). Several studies, demonstrating sex differences in vascular tone, 17 -20 provide evidence for involvement of the sex hormones E2 and T. In general, most suggest that T is a relative vasoconstrictor and E2 is a relative vasodilator via activation of endothelial nitric oxide synthase (eNOS) and cyclooxygenase. These conclusions are not absolutes as there are examples where the reproductive hormones, per se, do not Sex dimorphism of microvascular exchange appear to regulate tone. 20 -22 Obviously, this is an area for additional study with a need for inclusion of the roles of P4, metabolites of T, epigenetics, and in utero sex genome programming.
2.6 Exchange and the permeability 'constants' 2.6.1 Assumptions in the assessment of exchange Widely held perceptions of exchange are that (i) arterioles do not participate in exchange; (ii) capillaries, given their large number, are the primary site for volume flux; and (iii) venules, given their 'leaky' walls and low pressures, are the primary site for protein flux. Consequently, venule leak index assesses solute flux to tissue, measures of CFC reflect exclusively the behaviour of capillaries, and capillary L p assesses tissue hydration. According to Eq. (1), two other conditions that could result in net vascular to tissue space fluid movement are if CFC increases and/or s decreases. In a study of lower limb venous compliance, CFC was determined as a sex difference could compromise the measures. Venous compliance was found to be lower and CFC higher in the females than the males. 7 CFC can increase acutely if L p increases or more vessels are perfused (increasing S). Likewise, compounds that elevate P s under conditions of constant perfusion will increase exchange as will those that change vascular tone without changing P s . A pervasive assumption, arising from the notion that P s (or L p ) is a constant and only changes in the pathophysiological state of inflammation, is that agents used to vasodilate an organ during measures of CFC or PS to maximize S do not, themselves, alter L p or P s .
Changes vs. basal P s and L p
In the heart 21, 22 and SKM, 23 -25 not only does the vasodilator adenosine (ADO) alter P s , but sex modifies the direction and magnitude of changes in P s ( Table 4) . The sex dependence changes in adaptation to endurance exercise training. 26 Sexual dimorphism in P s responses to ADO in juvenile rat SKM reveals a genomic component; in adults, the patterns of change reveal involvement of the sex hormones E2, P4, and T. 24, 25 Juvenile sexual dimorphism differs from adults and is displayed for albumin clearances from rat mesentery on exposure to insulin. 27 Similarly, data from two laboratories using identical methods on adult rats of a single sex demonstrate that platelet activating factor (PAF) elicits a greater change in L p for males 28, 29 relative to females 30, 31 (Table 4) .
Few comparisons of basal permeability (P s or L p ) exist for simultaneous studies of both sexes. To date, sex-linked differences in P s ( Table 4 ) have been seen only for adult rat SKM venules 25 and coronary venules of endurance-exercise-trained pigs. 26 Attempting to compare separate studies of males and of females is frustrated by the small sample sizes and lack of statistical power.
The status of exchange from measures of blood volume, plasma volume, and volume handling
Absolute plasma volume (PV) and blood volume (BV) of conscious male rats exceed that of age-matched females ( Table 3) . When normalized to body weight, female volumes are greater than males. Once sex differences in haematocrit are accounted for, PV and BV (per 100 g) are 18 and 14% higher, respectively, in females. 32 Renal function, which obviously influences fluid balance, displays remarkable sex differences in the Munich-Wistar rat (MWF/Ztm), a strain studied extensively for the higher number of superficial glomeruli. Protein excretion rates in MWF/Ztm males at 7 weeks are double than that of females (note: 7 week males are juveniles; females mature), by 21 weeks the difference is 10-fold. 33 Insulin clearance and single nephron glomerular filtration rate are elevated in males in the face of comparable mean glomerular capillary pressure and transcapillary pressure gradient. Despite sex-independence in 
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Sex dimorphism of microvascular exchange number or size of glomeruli, CFC is higher in males than females 33 ( Table 3) . Only in male rats does chronic volume overload (via infrarenal aorto-caval fistula) result in 10-fold greater mortality, greater increases in left and right ventricular mass, increased lung weight and development of heart failure. 34 This illustrates a case where an identical stimulus, volume overload, elicits a sex-specific response.
3. Mechanisms responsible for the sexual dimorphisms 3.1 Genomics vs. sex hormones: juveniles vs. adults
Studies of sexual dimorphism of vascular function focus mainly on adults. There has been recent evidence for differences existing in prepubertal children and starting in utero via foetal programming. For example, EC-dependent and EC-independent responses examined children (11 years) of both sexes a decade after they had been on diets restricting saturated fats were compared with age-matched children. Boys of the diet-intervention group had increased EC-dependent dilatation responses relative to their age-matched controls ( Table 3) ; diet was without effect in the girls. 35 These differences in the control of vascular tone have potential impact on the regulation of exchange via control of S and pressure as discussed previously.
Epigenetics
Another mechanism that can induce sex differences is epigeneticsthose gene activities not involving alterations to genetic code, per se, but modifying phenotype and able to influence passage of genetic information to at least one successive generation. These patterns of gene expression are governed by cellular material, the epigenome, in close proximity to (just outside-hence the prefix epi) the genome. These epigenetic 'marks', via the addition of a methyl group to the epigenome (DNA methylation), provide on/off and amplitude of gene expression. Factors shown to influence these epigenetic marks include environmental toxins, diet, and stress. Nutritional status and stresses during pregnancy can also alter CV responses and disease susceptibility of the mother and offspring. Moderate protein restriction during gestation in rats results in remarkable increases in BP and decreases in nephron number in male, not female, offspring 36 ( Table 3) . Rodford et al. 37 demonstrated that same prenatal intervention induces sex differences in EC function. The most striking are reduced resistance artery responsiveness to ACH, increased arterial eNOS mRNA expression, and decreased HO-1 mRNA expression in the liver of male, not female, offspring. 37 Why female offspring should be resistant to maternal nutritional status during pregnancy is the focus of current study. To date, the mechanisms are not known.
Sex hormones
The role of the reproductive sex hormones is not simple. On their own, sex hormones can alter VSM tone ( Table 3 ) and multiple functions involved in exchange appear to change with the female reproductive cycle. 38 E2, particularly through non-genomic actions, influences EC NO production. 17 With respect to basal SKM and coronary and mesenteric microvessel P s albumin , the reproductive cycle per se appears to be without influence. 21 -24 This does not mean that some of the responses could not be secondary to sex hormones.
Androgens
Androgens, including testosterone, T, have been shown to up-regulate volume regulatory hormone expression, including arginine vasopressin receptor mRNA only in male hamster brain. 39 Relative to males, macrophages from female donors express lower levels of androgen receptor. 40 Androgens up-regulate VSM thromboxane receptors 41 and macrophage foam cell formation exclusively in males. 42 Male macrophages express .4-fold higher androgen receptor mRNA and up-regulate .25 genes mediating lipoprotein processing, cells surface adhesion, extracellular signalling, coagulation and fibrinolysis, and transport proteins. The macrophages illustrate sexual dimorphism of atherosclerotic potential, a process associated with altered exchange barrier function, exclusive to healthy males compared with age-matched females. 42 
Female menstrual cycle: oestrogen (E2) and progesterone (P4)
Changes in PV of females do not correlate uniformly with the menstrual cycle phase ( Table 5) . A recent study of healthy young males and females before and after exercise was designed to measure haemodynamics and sex hormones with sufficient statistical power to compare between sexes. 43 It was presumed that E2 and P4 would influence arterial BP and extracellular fluid volume regulation by increasing PV when E2 rose and by contracting PV when P4 rose during the menstrual cycle. Consistent with previous reports, 2 SBP of men . women at all phases of the cycle; DBP was sexindependent. Cardiac output was higher in men than women in early follicular (EF) and ovulatory (OV) phases, but not midluteal (ML) phase. Stroke volume in men was higher than women at all phases. No M/F differences in femoral blood flow or femoral, thigh, or forearm cutaneous vascular conductance existed. PV and BV were higher in the OV compared with EF or ML. Thus while endogenous E2 and P4 levels changed with menstrual cycle and differed with sex and PV fluctuated, the changes were not linked to plasma hormone levels. 43 No direct measures of P s or J v have been made as a function of the menstrual cycle. The dose-response relationship of E2 and mesenteric microvessel L p reveals a multi-phasic relationship with increases in L p when E2 was at levels grossly comparable to ovulation and pregnancy. 44 Limited studies exist of volume status and fluid distribution in normally cycling females. In one interstitial hydrostatic pressure, P i , and p were measured using the 'wick-in-needle' and the 'wick' 
H. Huxley and J. Wang methods, respectively. 45 From the follicular to luteal phase of the menstrual cycle a slight weight gain was accompanied by significant drops in plasma and interstitial p ( 2 mmHg) in the absence of changes in P i , albumin, haemoglobin, or haematocrit. 45 
Exchange barrier responses to non-reproductive hormones and non-hormonal mediators
In addition to E2 and P4, hormones influencing volume exchange include the natriuretic peptides (ANP, BNP, and CNP), angiotensin II (AII), and Aldo. These hormones exert effects in the kidney, resistance and exchange microvasculature, and brain to affect fluid exchange. The brain, an organ mentioned only superficially for the sake of brevity, has been studied most extensively with respect to sexual dimorphism and where foetal programming and pre-pubertal sex differences were first identified.
Renin-angiotensin -aldosterone system
It is notable that E2 and its receptor ER mediate protection from HTN induced by effector components of the renin-angiotensinaldosterone system. Low-dose ANG II or ALDO brain infusion result in markedly greater HTN in male compared with female rodents 46, 47 (Table 3 ) and the response is reversed by E2. 47 
Natriuretic peptides
Levels of the natriuretic peptides (NP) vary with sex in health and disease. 48 The NP will induce volume redistribution via renal actions of diuresis and natriuresis. In resistance vessels, NP can dilate VSM to increase functional exchange surface area and elevate pressure. 48 NP also acts directly in selected organs to increase L p and P s resulting in a fluid shift from the vascular to the interstitial space to reduce PV. 48 Plasma levels of N-terminal pro-A-type NP (Nt-ANP), N-terminal pro-B-type NP (Nt-BNP), and BNP
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( Table 2 ) increase with age and are higher in women than men. Higher NP levels are associated with lower free-T levels 50 and there is significant extracardiac transcription of NP in the ovaries and uterus, even after menopause. Women also have lower plasma levels of renin, known to be inversely associated with NP levels.
50
A diagnostic marker for congestive heart failure is a rise in plasma levels of NP; in this disease state sex differences in NP are lost 51 ( Table 2) . It is not known whether the ability of the NP to alter permeability 26 differs with sex in health or disease, or with menstrual cycle, or during pregnancy when volume expansion occurs.
Non-hormonal markers
A study of non-hormonal plasma markers associated with CV disease in .2000 individuals demonstrated higher levels of 29 and lower levels of 6 markers in females. 52 One set of markers (acute phase reactants including C-reactive protein, ICAM, RAGE) related to inflammation would influence exchange directly. The others, relating more indirectly, influence lipid profile (HDL-component ApoA-I, VLDL-component ApoC-III, Lp(a), ApoE) and metabolism with elevated adipokines associated with both truncal obesity and glucose intolerance (leptin and resistin) offset by the insulin-sensitizing and cardio-protective adiponectin. There are suggestions that adipokines mediate elevations in microvessels permeability in the vicinity of fat cells facilitating lipid removal and storage.
Inflammatory mediators
In healthy subjects, no sex differences exist for TNF-a and Interleukin-6 (IL-6), two inflammatory mediators known to alter EC barrier function. In response to stimuli, sex differences appear (Table 3) . Postprandially, a high-fat meal depresses TNF-a and elevates IL-6. The magnitude of these transients being greater in women than men with comparable C-reactive protein levels. 53 In response to sleep deprivation, females have a greater immune response with higher levels of TNF-a and IL-6 that remain elevated 12-18 h. 54 Finally, endotoxemic challenges result in higher TNF-a levels and greater loss of cardiac function in male than female mice that were abrogated by E2 treatment. 55 The cell signalling components correlating with these changes were higher Rac1 and NADPH oxidase activity, ERK1/2, and p38 MAPK phosphorylation, and toll-like receptor-4 (TLR-4) expression up-regulation. 55 A common approach in the early treatment of diabetes mellitus is the use of peroxisome proliferator activated receptor gamma (PPARgamma) antagonists. In coronary artery disease (CAD) patients, monocyte PPAR-gamma gene expression is .50-fold higher than healthy donors that released spontaneously higher amounts of pro-inflammatory cytokines. PPAR-gamma protein expressed from monocytes of CAD females greater than males and have the lowest basal TNF-a release inferring sex differences in response to PPARgamma agonist therapy. 56 Of interest, a side effect of thiazolidinedione therapy is oedema formation. Recent studies demonstrate that VEGF levels rise and remain elevated following treatment with at least two thiazolidinedione compounds. 57 Taken together, these studies point to possible sex-linked differences in response to PPAR-gamma agonists that have not been explored.
Foetal programming
Although a role for sex hormones mediating CV structure and function has been documented, little is known of the association between vascular sexual dimorphism and genes encoded on sex chromosomes. Increasing evidence, alluded to above, demonstrates sex differences in vascular function including BP, flow, and EC-dependent vascular reactivity that are either programmed in utero or observed in pre-pubertal children.
In humans, T production by the foetal testis is detectable at 9 weeks, peaks between 14 and 17 weeks and then falls sharply, so that by late pregnancy serum T concentrations of male and female foetuses overlap. 58 Ovarian endocrine activity begins shortly after birth; E2 levels are significantly higher in pre-pubertal girls than boys 9 ( Table 1) . Given the low and non-cycling reproductive hormone levels of children in the face of multiple sex-specific differences, the importance of genotype-sex interactions requires additional research attention.
3.6 Sex chromosomes 3.6.1 Y chromosome The Y chromosome, unique to genetic males, imparts male-specific phenotypes. In a set of elegant studies using consomic rats, the Y chromosome from normotensive WKY was replaced with that from spontaneous hypertensive rats (SHR) and vice versa. 59 The SHR background rats with the WKY Y chromosome had reduced systolic BP. WKY rats with the SHR Y chromosome had BP higher than WKY controls. Among six divergent loci of SRY, a gene encoding a transcription factor responsible for testes development, SRY1, was identified to be responsible for the increased systemic BP in SHR rats.
Studies using these consomic techniques to focus on exchange could provide insight into the mechanisms regulating exchange in juveniles and adults of both sexes and in several disease states.
X chromosome and X chromosome inactivation
Genes on one X chromosome are silenced randomly through X chromosome inactivation. Some genes, though, 'escape' X chromosome inactivation and are expressed by both copies of the chromosome, the process referred to as 'differential X chromosome-linked gene dosage'. This process contributes to sexual-dimorphism and contrasts with the dogma that dosage compensation for X-linked gene ensures equal X chromosome expression between males (XY) and females (XX) by transcriptional silencing of one X chromosome in XX female embryo. 61 Females with Turner's syndrome, possessing 45 monosomic X-chromosomes, have a variety of developmental and functional disorders including abnormal growth, metabolic dysfunction, high BP, vascular architecture anomalies, and foetal lymphedaema. 62, 63 This genetic abnormality illustrates the importance of genes escaping X-inactivation on the second X chromosome for females to develop and function normally and to contribute to sexually dimorphism in health and disease.
Sexual dimorphism at the cellular level
Given that each cell retains sex and that sex differences in cell signalling exist is interesting. Selected examples demonstrate the levels at which sexual dimorphism exists. EC from microvessels isolated from SKM of male and female rats. 66 Expression levels of PDE1A (male . female) and PDE3B (male , female) mRNA are sex-dependent, while PDE2A, PDE4D, and PDE5A are sex-independent ( Table 4 ). These findings suggest that cells retain intrinsic and inheritable sexually dimorphic genes in culture. Notably, male EC expressed the SRY gene even in culture. PDE2A, 3B, and 4D hydrolyze cAMP. Application of the PDE3 inhibitor, cilostazol, to microvascular EC monolayers results in reduced P s albumin solely in male, not female, cells from the comparable sex-independent basal P s . These pharmacological data demonstrate that sexually dimorphic genes have profound influence on cellular and tissue structure and function.
Aquaporins
The aquaporin family of proteins provides additional insights in the molecular mechanisms regulating transcellular water transport 67 and sex differences therein. Its first member, aquaporin (AQP)-1 (or CHIP28), a 28 kDa channel-forming integral membrane protein was identified initially in erythrocytes and later in the kidney. 68 AQP-1 has been identified in the apical and basolateral membranes of EC lining capillaries of several tissues. 68 Functional rat studies 68 and data from genetically modified mice 69 suggest that AQP-1 is the molecular counterpart of the ultra-small pores predicted by fluid transport theory. 70 The majority of peritoneal membrane J v during peritoneal dialysis is thought to occur through the tetrameric AQP-1 structures that assemble in plasma membrane. 71 Sexual dimorphism with respect to AQP-1 was found during the development of a C57BL/6J mouse model of peritoneal dialysis ( Table 3) . Females, relative to males, while possessing a similar peritoneal transport rate for small solutes, had lower sodium sieving that correlated directly with lower peritoneum AQP-1 mRNA and protein expression. 71 Studies in humans and rodents demonstrate specific localization of AQP-1 in capillary, venular, and lymphatic EC but not in small-size arteries, 72 consistent with the notion that water movement occurs primarily across the walls of low-pressure microvessels. It is not known how lower AQP-1 expression influences L p and/or the pressure dependence of J s . AQP-1 expression and contribution to transcellular fluid flux can be up-regulated by corticosteroids. 73 Given the well-characterized sex differences in adrenal cortical secretion, 74 the untested inference is that 'stressed states' would be accompanied by an increase in L p .
Receptor distribution
Receptor distributions, including those for the gonadal hormones, can play a role in manifestation of sex differences. In cutaneous vessels, the endothelin-B receptor mediates tonic vasoconstriction in males and vasodilatation in females. 75 The functional sexual dimorphism with respect to P s observed in adult and juvenile rat SKM and adult porcine coronary vessels could not be accounted for by differences in ADO receptors. 23 -25 These examples point to sex differences in cell signalling mechanisms elicited in response to receptor occupation and the potential for sexually dimorphic responses to vasoactive drugs.
Summary
Close inspection of the components regulating fluid and solute flux reveals multiple features that vary by sex. These features range from differences in the magnitude of the driving gradients, to the vascular structures, cell signalling mechanisms, inflammatory mediators, and circulating hormones. As both sexes are in volume homeostasis, the means by which this state is achieved must result from the combination of elements particular to each sex. Reproductive hormones contribute to sex differences through genomic and non-genomic interactions. Sex-specific phenotypes also arise prior to sexual maturity and are maintained by cells in culture in the absence of reproductive hormones implicating sex-specific gene expression. Evidence was presented demonstrating sex differences only following stimulation or perturbations to the system. Why should we care? Because manifestation of CV disease with respect to exchange can differ by sex with trivial to profound consequences-failure to recognize the differences can result in morbidity and mortality. While men and women can regulate these functions differently, the extent of the sex-sensitive differences, the mechanisms, and how they interact remain to be elucidated fully.
